Adeline Vanderver1, Morgan Prust2, Davide Tonduti3, Fanny Mochel4, Heather M Hussey5, Guy Helman2, James Garbern6, Florian Eichler7, Pierre Labauge8, Patrick Aubourg9, Diana Rodriguez10, Marc C Patterson11, Johan L K Van Hove12, Johanna Schmidt2, Nicole I Wolf13, Odile Boespflug-Tanguy14, Raphael Schiffmann15, Marjo S van der Knaap13. 1. Department of Neurology and Center for Genetic Medicine Research, Children's National Health System, Washington DC, USA; Department of Integrated Systems Biology, George Washington University School of Medicine, Washington DC, USA. Electronic address: avanderv@childrensnational.org. 2. Department of Neurology and Center for Genetic Medicine Research, Children's National Health System, Washington DC, USA. 3. Child Neuropsychiatry Unit, Department of Brain and Behavioral Sciences, University of Pavia, Italy; Department of Child Neurology, Fondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy. 4. INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM and APHP, Department of Genetics, Groupement Hospitalier Pitié-Salpêtrière-Charles Foix, Paris, France. 5. Milken Institute School of Public Health, The George Washington University, Washington DC, USA. 6. University of Rochester, Rochester, NY, USA. 7. Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 8. Department of Neurology, CHU Montpellier, Montpellier, France. 9. Department of Pediatric Neurology-Inserm U986, Hôpital Bicêtre, 78 avenue du Général Leclerc, 94275 Le Kremlin-Bicêtre, France. 10. APHP, Service de Neuropédiatrie, Hôpital Armand Trousseau, UPMC Universite, Paris 06, Inserm U676, Paris, France. 11. Departments of Neurology, Pediatrics and Medical Genetics, Mayo Clinic, Rochester, MN, USA. 12. Section of Genetics, Department of Pediatrics, University of Colorado, Aurora, CO, USA. 13. Department of Child Neurology, VU University Medical Center and Neuroscience Campus, Amsterdam, The Netherlands. 14. Department of Pediatric Neurology and Metabolic Disorders, French Reference Center for Leukodystrophies, Robert Debré Hospital, Paris, France; Inserm UMR1141 Neuroprotect, Paris Diderot University, Sorbonne Cite, Paris, France. 15. Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX, USA.
Abstract
OBJECTIVE: An approved definition of the term leukodystrophy does not currently exist. The lack of a precise case definition hampers efforts to study the epidemiology and the relevance of genetic white matter disorders to public health. METHOD: Thirteen experts at multiple institutions participated in iterative consensus building surveys to achieve definition and classification of disorders as leukodystrophies using a modified Delphi approach. RESULTS: A case definition for the leukodystrophies was achieved, and a total of 30 disorders were classified under this definition. In addition, a separate set of disorders with heritable white matter abnormalities but not meeting criteria for leukodystrophy, due to presumed primary neuronal involvement and prominent systemic manifestations, was classified as genetic leukoencephalopathies (gLE). INTERPRETATION: A case definition of leukodystrophies and classification of heritable white matter disorders will permit more detailed epidemiologic studies of these disorders.
OBJECTIVE: An approved definition of the term leukodystrophy does not currently exist. The lack of a precise case definition hampers efforts to study the epidemiology and the relevance of genetic white matter disorders to public health. METHOD: Thirteen experts at multiple institutions participated in iterative consensus building surveys to achieve definition and classification of disorders as leukodystrophies using a modified Delphi approach. RESULTS: A case definition for the leukodystrophies was achieved, and a total of 30 disorders were classified under this definition. In addition, a separate set of disorders with heritable white matter abnormalities but not meeting criteria for leukodystrophy, due to presumed primary neuronal involvement and prominent systemic manifestations, was classified as genetic leukoencephalopathies (gLE). INTERPRETATION: A case definition of leukodystrophies and classification of heritable white matter disorders will permit more detailed epidemiologic studies of these disorders.
Authors: R Basson; J Berman; A Burnett; L Derogatis; D Ferguson; J Fourcroy; I Goldstein; A Graziottin; J Heiman; E Laan; S Leiblum; H Padma-Nathan; R Rosen; K Segraves; R T Segraves; R Shabsigh; M Sipski; G Wagner; B Whipple Journal: J Urol Date: 2000-03 Impact factor: 7.450
Authors: Y Akwa; D E Hassett; M L Eloranta; K Sandberg; E Masliah; H Powell; J L Whitton; F E Bloom; I L Campbell Journal: J Immunol Date: 1998-11-01 Impact factor: 5.422
Authors: Jane T van Heteren; Flore Rozenberg; Eleonora Aronica; Dirk Troost; Pierre Lebon; Taco W Kuijpers Journal: Glia Date: 2008-04 Impact factor: 7.452
Authors: Marjan E Steenweg; Daniele Ghezzi; Tobias Haack; Truus E M Abbink; Diego Martinelli; Carola G M van Berkel; Annette Bley; Luisa Diogo; Eugenio Grillo; Johann Te Water Naudé; Tim M Strom; Enrico Bertini; Holger Prokisch; Marjo S van der Knaap; Massimo Zeviani Journal: Brain Date: 2012-04-04 Impact factor: 13.501
Authors: Jonathan B Rosenberg; Stephen M Kaminsky; Patrick Aubourg; Ronald G Crystal; Dolan Sondhi Journal: J Neurosci Res Date: 2016-11 Impact factor: 4.164
Authors: Alexander Conant; Julian Curiel; Amy Pizzino; Parisa Sabetrasekh; Jennifer Murphy; Miriam Bloom; Sarah H Evans; Guy Helman; Ryan J Taft; Cas Simons; Matthew T Whitehead; Steven A Moore; Adeline Vanderver Journal: J Child Neurol Date: 2018-06-08 Impact factor: 1.987
Authors: Cas Simons; Laurie B Griffin; Guy Helman; Gretchen Golas; Amy Pizzino; Miriam Bloom; Jennifer L P Murphy; Joanna Crawford; Sarah H Evans; Scott Topper; Matthew T Whitehead; John M Schreiber; Kimberly A Chapman; Cyndi Tifft; Katrina B Lu; Howard Gamper; Megumi Shigematsu; Ryan J Taft; Anthony Antonellis; Ya-Ming Hou; Adeline Vanderver Journal: Am J Hum Genet Date: 2015-03-26 Impact factor: 11.025
Authors: Ravi Datar; Asuri Narayan Prasad; Keng Yeow Tay; Charles Anthony Rupar; Pavlo Ohorodnyk; Michael Miller; Chitra Prasad Journal: Neuroradiol J Date: 2018-03-08
Authors: Guy Helman; Keith Van Haren; Joshua L Bonkowsky; Genevieve Bernard; Amy Pizzino; Nancy Braverman; Dean Suhr; Marc C Patterson; S Ali Fatemi; Jeff Leonard; Marjo S van der Knaap; Stephen A Back; Stephen Damiani; Steven A Goldman; Asako Takanohashi; Magdalena Petryniak; David Rowitch; Albee Messing; Lawrence Wrabetz; Raphael Schiffmann; Florian Eichler; Maria L Escolar; Adeline Vanderver Journal: Mol Genet Metab Date: 2015-02-07 Impact factor: 4.797
Authors: Haille E Soderholm; Alexander B Chapin; Pinar Bayrak-Toydemir; Joshua L Bonkowsky Journal: Pediatr Neurol Date: 2020-06-17 Impact factor: 3.372